Finance

Beta
Lists
003017:SHE
Zhejiang Dayang Biotech Group Co Ltd
CN¥27.14
-1.17%
(-0.32) 1D
Jun 24, 9:41:57 AM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 003017...
Open
CN¥27.41
High
CN¥27.70
Low
CN¥27.00
Mkt. cap
2.26B
Avg. vol.
2.70M
Volume
300.09K
Dividend
2.21%
Quarterly dividend
CN¥0.15
Ex-dividend date
Jun 26, 2026
P/E ratio
21.95
52-wk high
CN¥37.99
52-wk low
CN¥24.69
EPS
CN¥1.24
Shares outstanding
84.00M
No. of employees
771
Open
CN¥27.41
High
CN¥27.70
Low
CN¥27.00
Mkt. cap
2.26B
Avg. vol.
2.70M
Volume
300.09K
Dividend
2.21%
Quarterly dividend
CN¥0.15
Ex-dividend date
Jun 26, 2026
P/E ratio
21.95
52-wk high
CN¥37.99
52-wk low
CN¥24.69
EPS
CN¥1.24
Shares outstanding
84.00M
No. of employees
771
News stories
From sources across the web
About Zhejiang Dayang Biotech Group Co Ltd
CEO-
Employees771
FoundedJan 1, 1976
Headquarters-
SectorSpeciality chemicals
Websitedyhg.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
250.34M
248.00M
298.13M
278.13M
Cost of goods sold
188.92M
190.70M
238.70M
212.88M
Cost of revenue
188.92M
190.70M
238.70M
212.88M
Research and development expenses
8.33M
10.42M
16.08M
9.06M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
22.57M
21.90M
19.40M
23.53M
Operating expense
31.31M
23.33M
43.58M
30.34M
Total operating expenses
220.22M
214.02M
282.28M
243.22M
Operating income
30.12M
33.97M
15.85M
34.90M
Other non operating income
176.50K
-468.53K
147.23K
-1.34M
EBT including unusual items
23.70M
27.44M
24.77M
34.76M
EBT excluding unusual items
31.28M
34.44M
18.83M
35.18M
Income tax expense
2.73M
-1.92M
4.37M
3.86M
Effective tax rate
11.53%
-7.00%
17.62%
11.09%
Other operating expenses
1.25M
-8.84M
7.19M
-4.28M
Net income
21.16M
29.53M
19.82M
30.87M
Net profit margin
8.45%
11.91%
6.65%
11.10%
Earnings per share
-
-
-
-
Interest and investment income
1.93M
2.37M
3.66M
2.41M
Interest expense
-1.44M
-940.75K
-919.14K
-785.64K
Net interest expenses
492.50K
1.43M
2.74M
1.62M
Depreciation and amortization charges
-
-
-
-
EBITDA
46.13M
50.83M
33.69M
52.73M
Gain or loss from assets sale
-
-
-2.05M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer